Teva Homepage Print this page Site Map
Teva investor relationsAbout TevaTeva Worldwide

Investor Relations

Webcasts  
Email Alerts
Get Email Alerts


Stock Info


Financial Quick Links

Special Meeting of Shareholders
September 25, 2008
Voting Results

Notice of Special Meeting of
Shareholders 2008
Proxy Statement

Notice of Annual Meeting of
Shareholders 2008
Proxy Statement

Third Quarter 2008
Revised Geographical Sales
Figures 2007
 
More...


Notices Relating to Convertible Debentures
November 14, 2008
Replay : Presentation at the 2008 Credit Suisse Annual Healthcare Conference
November 6, 2008
Replay : 3rd Quarter 2008 Earnings Conference Call

     More...
 
   
Presentations  
December 1, 2008
Teva Investor Presentation -
Merril Lynch Generic Conference - PPT 7.07 MB

September 24, 2008
UBS Global Life Sciences Conference - PDF 4.1 MB

    More...
 
   
News & PR  
Jerusalem, Israel, November 25, 2008
Teva Announces Agreement on Generic Pulmicort Respules® Patent Challenge

Jerusalem, Israel, November 20, 2008
Teva Provides Update on Generic Pulmicort Repulses® Launch

Jerusalem, Israel, November 19, 2008
Teva Receives First U.S. Approval for Generic Pulmicort Respules®; Commences Commercial Launch

    More...

 

 

 
   




Back to Top